{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:20:17Z","timestamp":1768828817555,"version":"3.49.0"},"reference-count":74,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,6]]},"abstract":"<jats:p>Antimicrobial resistance (AMR) is a growing threat to global health. Although AMR endangers continued effectiveness of antibiotics, the impact of AMR has been poorly estimated in low-income countries. This study sought to quantify the effect of AMR on treatments for pediatric pneumococcal disease in Ethiopia. We developed the DREAMR (Dynamic Representation of the Economics of AMR) model that simulate children younger than 5 years who acquire pneumococcal disease (pneumonia, meningitis, and acute otitis media) and seek treatment from various health facilities in Ethiopia over a year. We examined the AMR levels of three antibiotics (penicillin, amoxicillin, and ceftriaxone), treatment failures, and attributable deaths. We used the cost-of-illness method to assess the resulting economic impact of AMR from a societal perspective by estimating the direct and indirect treatment costs and productivity losses. Findings showed that AMR against antibiotics that were used to treat pneumococcal disease led to 195,763 treatment failures per year, which contributed to 2,925 child deaths annually in Ethiopia. Antimicrobial resistance resulted in a first-line treatment failure rate of 29.4%. In 1 year, the proportion of nonsusceptible <jats:italic>Streptococcus pneumoniae<\/jats:italic> bacteria increased by 2.1% and 0.5% for amoxicillin and penicillin, and reduced by 0.3% for less commonly used ceftriaxone. Annual costs of AMR to treat pneumococcal disease were around US$15.8 million, including US$3.3 million for ineffective first-line treatments, US$3.7 million for second-line treatments, and US$8.9 million for long-term productivity losses. Antibiotic stewardship to reduce misuse and overuse of antibiotics is essential to maintain the effectiveness of antibiotics, and lessen the health and economic burden of AMR.<\/jats:p>","DOI":"10.4269\/ajtmh.18-0930","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T07:00:33Z","timestamp":1568358033000},"page":"1042-1053","source":"Crossref","is-referenced-by-count":16,"title":["Impact of Antibiotic Resistance on Treatment of Pneumococcal Disease in Ethiopia: An Agent-Based Modeling Simulation"],"prefix":"10.4269","volume":"101","author":[{"given":"Hui-Han","family":"Chen","sequence":"first","affiliation":[{"name":"Division of Practice Advancement and Clinical Education, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Stringer","sequence":"additional","affiliation":[{"name":"Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadesse","family":"Eguale","sequence":"additional","affiliation":[{"name":"Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauri G.","family":"Rao","sequence":"additional","affiliation":[{"name":"Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Division of Practice Advancement and Clinical Education, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina;"},{"name":"Department of Maternal and Child Health, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"b1","series-title":"Science","first-page":"874","article-title":"Achieving global targets for antimicrobial resistance","volume":"353","author":"Laxminarayan","year":"2016"},{"key":"b2","series-title":"J Glob Health","first-page":"010306","article-title":"Global disease burden due to antibiotic resistance\u2013state of the evidence","volume":"6","author":"Woolhouse","year":"2016"},{"key":"b3","series-title":"About Antimicrobial Resistance","author":"Centers for Disease Control and Prevention","year":"2017"},{"key":"b4","series-title":"Molecules","first-page":"5286","article-title":"Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities","volume":"20","author":"Penesyan","year":"2015"},{"key":"b5","series-title":"Wound Healing South Afr","first-page":"30","article-title":"The state of the world\u2019s antibiotics 2015","volume":"8","author":"Gelband","year":"2015"},{"key":"b6","series-title":"P T","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola","year":"2015"},{"key":"b7","series-title":"Clin Infect Dis","first-page":"S71","article-title":"The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett","volume":"59","author":"Spellberg","year":"2014"},{"key":"b8","series-title":"Tackling Drug-Resistant Infections Globally: Final Report and Recommendations","author":"O\u2019Neill","year":"2016"},{"key":"b9","series-title":"Clin Microbiol Infect","first-page":"973","article-title":"Economic burden of antibiotic resistance: how much do we really know?","volume":"20","author":"Gandra","year":"2014"},{"key":"b10","series-title":"Antibiotic Resistance Threats in the United States, 2013","author":"Centers for Disease Control and Prevention","year":"2013"},{"key":"b11","series-title":"The Bacterial Challenge: Time to React a Call to Narrow the Gap Between Multidrug-Resistant Bacteria in the EU and Development of New Antibacterial Agents","author":"European Medicines Agency (EMA) and European Center for Disease Prevention and Control (ECDC)","year":"2009"},{"key":"b12","series-title":"BMC Med","first-page":"81","article-title":"Population-level mathematical modeling of antimicrobial resistance: a systematic review","volume":"17","author":"Niewiadomska","year":"2019"},{"key":"b13","series-title":"Antimicrobial Resistance: Global Report on Surveillance","author":"WHO","year":"2014"},{"key":"b14","series-title":"Lancet","first-page":"1405","article-title":"Global burden of childhood pneumonia and diarrhoea","volume":"381","author":"Walker","year":"2013"},{"key":"b15","series-title":"An Introduction to Agent-Based Modeling: Modeling Natural, Social, and Engineered Complex Systems with NetLogo","author":"Wilensky","year":"2015"},{"key":"b16","series-title":"Pathog Dis","first-page":"fty059","article-title":"Implementation and applications of EMOD, an individual-based multi-disease modeling platform","volume":"76","author":"Bershteyn","year":"2018"},{"key":"b17","series-title":"NetLogo: Center for Connected Learning and Computer-Based Modeling","author":"Wilensky","year":"1999"},{"key":"b18","series-title":"Asian Pac J Trop Biomed","first-page":"536","article-title":"Antimicrobial susceptibility patterns of Streptococcus pneumoniae over 6 years at Gondar University Hospital, northwest Ethiopia","volume":"3","author":"Anagaw","year":"2013"},{"key":"b19","series-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fifth Informational Supplement","author":"Clinical Laboratory Standards Institute","year":"2015"},{"key":"b20","series-title":"Clin Microbiol Infect","first-page":"418","article-title":"Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values","volume":"12","author":"Turnidge","year":"2006"},{"key":"b21","series-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"b22","series-title":"Bull World Health Organ","first-page":"15","article-title":"The second international standard for penicillin","volume":"9","author":"Humphrey","year":"1953"},{"key":"b23","series-title":"Pharmacol Toxicol","first-page":"259","article-title":"Malnutrition and pharmacokinetics of penicillin in Ethiopian children","volume":"76","author":"Bolme","year":"1995"},{"key":"b24","series-title":"Antimicrob Agents Chemother","first-page":"252","article-title":"Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients","volume":"23","author":"Schaad","year":"1983"},{"key":"b25","series-title":"Antimicrob Agents Chemother","first-page":"191","article-title":"Pharmacokinetics of ceftriaxone in pediatric patients with meningitis","volume":"23","author":"Steele","year":"1983"},{"key":"b26","series-title":"Children (Basel)","first-page":"E27","article-title":"Nasopharyngeal carriage and antimicrobial susceptibility patterns of Streptococcus pneumoniae among children under five in southwest Ethiopia","volume":"4","author":"Gebre","year":"2017"},{"key":"b27","series-title":"Introduction to Drug Utilization Research","author":"WHO, International Working Group for Drug Statistics Methodology, Collaborating Centre for Drug Statistics Methodology, Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services","year":"2003"},{"key":"b28","series-title":"Clin Infect Dis","first-page":"e25","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011"},{"key":"b29","series-title":"Red Book: 2015 Report of the Committee on Infectious Diseases","article-title":"Pneumococcal infections","author":"American Academy of Pediatrics","year":"2015"},{"key":"b30","series-title":"Revista M\u00e9dica Cl\u00ednica Las Condes","first-page":"615","article-title":"Optimizing antimicrobial phamacodynamics: a guide for your stewardship program","volume":"27","author":"Kuti","year":"2016"},{"key":"b31","series-title":"Infect Med","first-page":"219","article-title":"Using pharmacodynamic and pharmacokinetic concepts to optimize treatment of infectious diseases","volume":"21","author":"Quintiliani","year":"2004"},{"key":"b32","series-title":"Diagn Microbiol Infect Dis","first-page":"89","article-title":"Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins","volume":"22","author":"Craig","year":"1995"},{"key":"b33","series-title":"Infect Dis Clin North Am","first-page":"791","article-title":"Pharmacokinetics and pharmacodynamics of antibacterial agents","volume":"23","author":"Levison","year":"2009"},{"key":"b34","series-title":"PLoS One","first-page":"e29407","article-title":"The fitness cost of antibiotic resistance in Streptococcus pneumoniae: insight from the field","volume":"7","author":"Maher","year":"2012"},{"key":"b35","series-title":"J Infect Dis","first-page":"S9","article-title":"Interplay between antibiotic resistance and virulence during disease promoted by multidrug-resistant bacteria","volume":"215","author":"Geisinger","year":"2017"},{"key":"b36","series-title":"Future Internet","first-page":"92","article-title":"Epidemic spreading in urban areas using agent-based transportation models","volume":"11","author":"Hackl","year":"2019"},{"key":"b37","series-title":"WHO\/UNICEF Coverage Estimates for 1980\u20132017","author":"WHO, UNICEF","year":"2018"},{"key":"b38","series-title":"Lancet Respir Med","first-page":"399","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study","volume":"4","author":"Moore","year":"2016"},{"key":"b39","series-title":"Lancet","first-page":"893","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009"},{"key":"b40","series-title":"PLoS One","first-page":"e36226","article-title":"Burden of disease caused by otitis media: systematic review and global estimates","volume":"7","author":"Monasta","year":"2012"},{"key":"b41","series-title":"Epidemiol Rev","first-page":"265","article-title":"Herd immunity: history, theory, practice","volume":"15","author":"Fine","year":"1993"},{"key":"b42","series-title":"Philos Trans R Soc Lond B Biol Sci","first-page":"20130433","article-title":"The contribution of vaccination to global health: past, present and future","volume":"369","author":"Greenwood","year":"2014"},{"key":"b43","series-title":"Vaccine","first-page":"4267","article-title":"Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland","volume":"30","author":"Blank","year":"2012"},{"key":"b44","series-title":"Ethiopia Demographic and Health Survey 2016","author":"Central statistical agency (CSA) [Ethiopia], ICF","year":"2016"},{"key":"b45","series-title":"Health Policy Plan","first-page":"214","article-title":"Infant mortality due to acute respiratory infections: the influence of primary care processes","volume":"12","author":"Reyes","year":"1997"},{"key":"b46","series-title":"BMJ Glob Health","first-page":"e000166","article-title":"Household expenditures on pneumonia and diarrhoea treatment in Ethiopia: a facility-based study","volume":"2","author":"Memirie","year":"2017"},{"key":"b47","series-title":"CMAJ","first-page":"335","article-title":"A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age","volume":"172","author":"Le Saux","year":"2005"},{"key":"b48","series-title":"Acute Otitis Media in Children: Treatment","author":"Klein","year":"2018"},{"key":"b49","series-title":"J Antibiotics Res","first-page":"106","article-title":"Retrospective drug use pattern of antibiotics in pediatric ward of Shenan Gibe Hospital, Oromia Region, Ethiopia","volume":"1","author":"Achalu","year":"2017"},{"key":"b50","series-title":"Pediatrics","first-page":"1087","article-title":"Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use","volume":"102","author":"Arditi","year":"1998"},{"key":"b51","series-title":"Penicillin G Potassium\u2013Penicillin G Injection, Solution","author":"Baxter Healthcare Corporation","year":"2016"},{"key":"b52","series-title":"A Study on the Public Health and Socioeconomic Impact of Substandard and Falsified Medical Products","author":"WHO","year":"2017"},{"key":"b53","series-title":"Thorax","first-page":"ii1","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011","volume":"66","author":"Harris","year":"2011"},{"key":"b54","series-title":"World Population Prospects: the 2017 Revision","author":"United Nations Department of Economic and Social Affairs Population Division","year":"2017"},{"key":"b55","series-title":"Pharmacoeconomics","first-page":"1","article-title":"Cost-of-illness studies","volume":"2","author":"Drummond","year":"1992"},{"key":"b56","series-title":"Milbank Mem Fund Q Health Soc","first-page":"429","article-title":"Cost-of-illness methodology: a guide to current practices and procedures","volume":"60","author":"Hodgson","year":"1982"},{"key":"b57","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"key":"b58","series-title":"GDP Per Capita (Current US$) 2016","author":"The World Bank","year":"2017"},{"key":"b59","series-title":"Lancet Glob Health","first-page":"e712","article-title":"Disability weights for the global burden of disease 2013 study","volume":"3","author":"Salomon","year":"2015"},{"key":"b60","series-title":"PLoS Med","first-page":"e1002416","article-title":"Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: a modelling study","volume":"14","author":"Whittles","year":"2017"},{"key":"b61","series-title":"Clin Microbiol Infect","first-page":"793","article-title":"What is antimicrobial stewardship?","volume":"23","author":"Dyar","year":"2017"},{"key":"b62","series-title":"Clin Infect Dis","first-page":"1091","article-title":"Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries","volume":"44","author":"Goossens","year":"2007"},{"key":"b63","series-title":"Bull World Health Organ","first-page":"191","article-title":"External quality assessment of national public health laboratories in Africa, 2002\u20132009","volume":"90","author":"Frean","year":"2012"},{"key":"b64","series-title":"Pediatr Infect Dis J","first-page":"1172","article-title":"Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics","volume":"19","author":"Melander","year":"2000"},{"key":"b65","series-title":"Preliminary Report on Antimicrobial Use and Resistance in Australia (AURA)","author":"Australian Commission on Safety and Quality in Health Care","year":"2014"},{"key":"b66","series-title":"J Antimicrob Chemother","first-page":"849","article-title":"Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniae","volume":"57","author":"Henderson-Begg","year":"2006"},{"key":"b67","series-title":"Science","first-page":"430","article-title":"Rapid pneumococcal evolution in response to clinical interventions","volume":"331","author":"Croucher","year":"2011"},{"key":"b68","series-title":"J Antimicrob Chemother","first-page":"616","article-title":"Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing","volume":"52","author":"Zinner","year":"2003"},{"key":"b69","series-title":"Int J Tuberc Lung Dis","first-page":"308","article-title":"Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis","volume":"17","author":"Bate","year":"2013"},{"key":"b70","series-title":"Cost-Effectiveness in Health and Medicine","author":"Neumann","year":"2016"},{"key":"b71","series-title":"Sustainable Development Goals","author":"United Nations","year":"2015"},{"key":"b72","author":"Global Health Security Agenda","year":"2018"},{"key":"b73","series-title":"PLoS One","first-page":"e0138179","article-title":"Inappropriate use of antibiotics and its associated factors among urban and rural communities of Bahir Dar city administration, northwest Ethiopia","volume":"10","author":"Gebeyehu","year":"2015"},{"key":"b74","series-title":"PLoS One","first-page":"e0138385","article-title":"Antimicrobial use-related problems and predictors among hospitalized medical in-patients in southwest Ethiopia: prospective observational study","volume":"10","author":"Yadesa","year":"2015"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/101\/5\/article-p1042.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/101\/5\/article-p1042.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/101\/5\/article-p1042.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T21:37:28Z","timestamp":1722461848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/101\/5\/article-p1042.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":74,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.18-0930","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]}}}